Certified by Founder Lodge
ARCH Venture Partners

INVESTOR
1 Disclosed Funding Rounds $261,000,000
17 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Early stage venture firm focused on life science discoveries to prevent, detect and cure disease.
Company | Date | Round | Raised |
---|---|---|---|
![]() |
October, 18 ,2022 | Series A | $261,000,000 |
![]() |
October, 17 ,2022 | Series B | $112,000,000 |
![]() |
August, 24 ,2022 | Series A | $60,000,000 |
![]() |
August, 03 ,2022 | Series B | $50,000,000 |
![]() |
January, 30 ,2023 | Series A | $200,000,000 |
![]() |
March, 08 ,2023 | Series A | $100,000,000 |
![]() |
March, 08 ,2023 | Series A | $60,000,000 |
![]() |
March, 09 ,2022 | Series A | $60,000,000 |
![]() |
April, 27 ,2023 | Series A | $270,000,000 |
![]() |
May, 17 ,2023 | Series C | $100,000,000 |
![]() |
May, 19 ,2023 | Unknown | $14,000,000 |
![]() |
May, 19 ,2023 | Unknown | $73,000,000 |
![]() |
June, 08 ,2023 | Series A | $25,000,000 |
![]() |
August, 18 ,2023 | Series B | $49,000,000 |
![]() |
September, 18 ,2023 | Series C | $273,000,000 |
![]() |
September, 20 ,2023 | Unknown | $50,000,000 |
![]() |
September, 20 ,2023 | Unknown | $30,000,000 |